// App-Quantinova.ai

POS03 : Novolimus-eluting bioresorbable scaffolds in the treatment of coronary artery disease: first results from an all-comers population

Researchers

Presenter

  • Wiebe J

Principal Investigators

  • Oliver D

  • Liebetrau C

  • Renker M

  • Ilstad H

  • Albrecht T

  • Bauer T

  • Elsasser A

  • Mollmann H

  • Ha MM C

  • Nef H

Medical Centers

  • University of Giessen, Giessen, Germany

  • Heart Centre Oldenburg, Oldenburg, Germany

  • Kerckhoff Heart and Thorax Center, Department of Cardiology, Bad Nauheim, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Stable coronary artery disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved